{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:17:07Z","timestamp":1791335827010,"version":"4.3.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.lungcan.2025.108806","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:58:32Z","timestamp":1761433112000},"page":"108806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Overall survival in patients with non-small cell lung cancer and leptomeningeal metastases: Data from the Dutch cancer Registry"],"prefix":"10.1016","volume":"209","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9117-6885","authenticated-orcid":false,"given":"Jarno W.J.","family":"Huijs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1594-2407","authenticated-orcid":false,"given":"Francesca R.","family":"Ogliari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7248-7047","authenticated-orcid":false,"given":"Ronald A.M.","family":"Damhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"Jongbloed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8834-2202","authenticated-orcid":false,"given":"Martinus P.G.","family":"Broen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique H.M.E.","family":"Anten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7998-9904","authenticated-orcid":false,"given":"Dieta","family":"Brandsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette H.R.J.","family":"Degens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk K.M.","family":"De Ruysscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3521-2535","authenticated-orcid":false,"given":"Lizza E.L.","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2025.108806_b0005","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ctrv.2016.12.006","article-title":"Leptomeningeal carcinomatosis in non-small cell lung cancer patients: a continuing challenge in the personalized treatment era","volume":"53","author":"Remon","year":"2017","journal-title":"Cancer Treat. Rev."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108806_b0010","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.lungcan.2012.03.002","article-title":"Clinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: Okayama Lung Cancer Study Group","volume":"77","author":"Umemura","year":"2012","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2025.108806_b0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/cncr.30911","article-title":"Leptomeningeal metastasis from systemic cancer: Review and update on management","volume":"124","author":"Wang","year":"2018","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.lungcan.2025.108806_b0020","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/jamaoncol.2022.7364","article-title":"Assessment of phase 3 Randomized Clinical Trials Including patients with Leptomeningeal Disease: a Systematic Review","volume":"9","author":"Sharma","year":"2023","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.lungcan.2025.108806_b0025","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.78.3118","article-title":"CNS Response to Osimertinib Versus Standard Epidermal Growth factor Receptor Tyrosine Kinase Inhibitors in patients with Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer","author":"Reungwetwattana","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.lungcan.2025.108806_b0030","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1200\/JCO.23.02219","article-title":"CNS Efficacy of Osimertinib with or without Chemotherapy in Epidermal Growth factor Receptor-Mutated Advanced Non-Small-Cell Lung Cancer","volume":"42","author":"J\u00e4nne","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"23","key":"10.1016\/j.lungcan.2025.108806_b0035","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1200\/JCO.24.00708","article-title":"Phase II Efficacy and Safety of 80 mg Osimertinib in patients with Leptomeningeal Metastases Associated with Epidermal Growth factor Receptor Mutation-positive Non-Small Cell Lung Cancer (BLOSSOM)","volume":"42","author":"Park","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.lungcan.2025.108806_b0040","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1158\/1078-0432.CCR-21-1838","article-title":"ASCEND-7: Efficacy and Safety of Ceritinib Treatment in patients with ALK-Positive Non-Small Cell Lung Cancer Metastatic to the Brain and\/or Leptomeninges","volume":"28","author":"Chow","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2025.108806_b0045","article-title":"Phase II Study of Lorlatinib in patients with Anaplastic Lymphoma Kinase-positive Lung Cancer and CNS-Specific Relapse","volume":"6","author":"Dagogo-Jack","year":"2022","journal-title":"JCO Precis. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108806_b0050","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1634\/theoncologist.2014-0309","article-title":"Alectinib induces a durable (>15 months) complete response in an ALK-positive non-small cell lung cancer patient who progressed on crizotinib with diffuse leptomeningeal carcinomatosis","volume":"20","author":"Ou","year":"2015","journal-title":"Oncologist"},{"issue":"8","key":"10.1016\/j.lungcan.2025.108806_b0055","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002473","article-title":"Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers","volume":"9","author":"Naidoo","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.lungcan.2025.108806_b0060","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejca.2019.05.019","article-title":"Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitors","volume":"116","author":"Hendriks","year":"2019","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.lungcan.2025.108806_b0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejca.2021.03.037","article-title":"Clinical outcomes of non-small cell lung cancer patients with leptomeningeal metastases after immune checkpoint inhibitor treatments","volume":"150","author":"Zheng","year":"2021","journal-title":"Eur. J. Cancer"},{"issue":"33","key":"10.1016\/j.lungcan.2025.108806_b0070","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1200\/JCO.22.01148","article-title":"Randomized phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for patients with Solid Tumor Leptomeningeal Metastasis","volume":"40","author":"Yang","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2025.108806_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.101624","article-title":"Leptomeningeal metastasis from solid tumours: EANO-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"8","author":"Le Rhun","year":"2023","journal-title":"ESMO Open"},{"issue":"1","key":"10.1016\/j.lungcan.2025.108806_b0080","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC Lung Cancer Staging Project: proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J. Thorac. Oncol."},{"issue":"7","key":"10.1016\/j.lungcan.2025.108806_b0085","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/neuonc\/noaa298","article-title":"Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumors","volume":"23","author":"Le Rhun","year":"2021","journal-title":"Neuro Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108806_b0090","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jns.2004.05.008","article-title":"Leptomeningeal metastasis: survival and prognostic factors in 155 patients","volume":"223","author":"Herrlinger","year":"2004","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.lungcan.2025.108806_b0095","article-title":"Combination of antiangiogenic and systemic therapy in advanced non-small cell lung cancer: before and after progression to leptomeningeal metastasis","volume":"15(1):11901","author":"Zhu","year":"2025","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.lungcan.2025.108806_b0100","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.lungcan.2011.11.022","article-title":"Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era","volume":"76","author":"Park","year":"2012","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2025.108806_b0105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s10555-024-10235-1","article-title":"Immunotherapy for leptomeningeal disease from solid tumors: current clinical outcomes and future opportunities","volume":"44","author":"Smith","year":"2024","journal-title":"Cancer Metastasis Rev."},{"issue":"6","key":"10.1016\/j.lungcan.2025.108806_b0110","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1007\/s13311-022-01261-4","article-title":"Leptomeningeal Metastases: New Opportunities in the Modern Era","volume":"19","author":"Wilcox","year":"2022","journal-title":"Neurotherapeutics"},{"issue":"4","key":"10.1016\/j.lungcan.2025.108806_b0115","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.annonc.2022.12.013","article-title":"Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Hendriks","year":"2023","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2025.108806_b0120","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jtho.2019.12.113","article-title":"Osimertinib for patients with Leptomeningeal Metastases Associated with EGFR T790M-positive Advanced NSCLC: the AURA Leptomeningeal Metastases Analysis","volume":"15","author":"Ahn","year":"2020","journal-title":"J. Thorac. Oncol."},{"issue":"9","key":"10.1016\/j.lungcan.2025.108806_b0125","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.050836","article-title":"Preclinical evaluation of targeted therapies for central nervous system metastases","volume":"17","author":"Pfeil","year":"2024","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.lungcan.2025.108806_b0130","article-title":"The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study","author":"Zheng","year":"2025","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2025.108806_b0135","article-title":"P16.02 Impact of Number and Location of Metastatic Sites on Survival in Stage IV ICI-Treated NSCLC","volume":"16(3):S348","author":"Gibson","year":"2021","journal-title":"J. Thorac. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108806_b0140","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.21037\/jtd-23-516","article-title":"Optimal therapeutic strategy for non-small cell lung cancer with thoracic extrathoracic metastasis: a study based on SEER database","volume":"16","author":"He","year":"2024","journal-title":"J. Thorac. Dis."},{"issue":"17","key":"10.1016\/j.lungcan.2025.108806_b0145","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1016\/j.ejca.2015.08.008","article-title":"Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: results from a population-based study","volume":"51","author":"Hendriks","year":"2015","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.lungcan.2025.108806_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.gmg.2025.100051","article-title":"Real-world prognostic factors for first-line EGFR-TKI efficacy in advanced NSCLC patients harboring EGFR 21L858R mutation","volume":"12","author":"Liu","year":"2025","journal-title":"Glob Med Genet."},{"issue":"6","key":"10.1016\/j.lungcan.2025.108806_b0155","first-page":"7589","article-title":"Impact of metastatic status on the prognosis of EGFR mutation-positive non-small cell lung cancer patients treated with first-generation EGFR-tyrosine kinase inhibitors","volume":"14","author":"Taniguchi","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.lungcan.2025.108806_b0160","unstructured":"National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Central Nervous System Cancers. Version 1.2025 2025 [Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cns.pdf]."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108806_b0165","article-title":"Radiation Therapy in the Management of Leptomeningeal Disease from Solid Tumors","volume":"9","author":"Barbour","year":"2024","journal-title":"Adv. Radiat. Oncol."},{"issue":"11","key":"10.1016\/j.lungcan.2025.108806_b0170","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/j.jtho.2016.06.029","article-title":"Leptomeningeal Metastases in patients with NSCLC with EGFR Mutations","volume":"11","author":"Li","year":"2016","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108806_b0175","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00432-022-04396-1","article-title":"Prognosticators of osimertinib treatment outcomes in patients with EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis","volume":"149","author":"Chiang","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"21","key":"10.1016\/j.lungcan.2025.108806_b0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218151","article-title":"Immunomodulatory Effects of Radiotherapy","volume":"21","author":"Kumari","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108806_b0185","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI67313","article-title":"Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice","volume":"124","author":"Deng","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lungcan.2025.108806_b0190","doi-asserted-by":"crossref","DOI":"10.1038\/s43018-025-01018-w","article-title":"Combination of pembrolizumab and radiotherapy induces systemic antitumor immune responses in immunologically cold non-small cell lung cancer","author":"Huang","year":"2025","journal-title":"Nature Cancer"},{"key":"10.1016\/j.lungcan.2025.108806_b0195","unstructured":"Federatie Medisch Specialisten. Leptomeningeale metastasen 2020 [Available from: https:\/\/richtlijnendatabase.nl\/richtlijn\/leptomeningeale_metastasen\/behandeling\/solide_tumoren.html]."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225006981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225006981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T12:51:42Z","timestamp":1763124702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500225006981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":39,"alternative-id":["S0169500225006981"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108806","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overall survival in patients with non-small cell lung cancer and leptomeningeal metastases: Data from the Dutch cancer Registry","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108806","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108806"}}